Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
Tom T. Shimabukuro, Matt Cole, John R. Su
Abstract
This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the CDC in the first month of use of the Pfizer-BioNTech and Moderna COVID-19 vaccines in the US, December 14, 2020-January 18, 2021.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Receipt2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AnaphylaxisPediatricsVirologyImmunologyAllergyInternal medicineOutbreakDiseaseComputer scienceWorld Wide WebInfectious disease (medical specialty)Food Allergy and Anaphylaxis ResearchDrug-Induced Adverse ReactionsVaccine Coverage and Hesitancy